Further studies (i.e., mouse models with specific COMP or ACAN mutation, expression studies, and biochemical investigation in cartilage or muscle samples) are needed to clarify the mechanisms leading to the clinical variability of MED and the association of very particular clinical characteristics such as OCD or myopathic signs. This evidence concerns the gene ACAN and osteochondritis dissecans.